This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japan's Terumo to buy UK organ-preservation company OrganOx for $1.5 billion

( August 25, 2025, 03:40 GMT | Official Statement) -- MLex Summary: Japan’s leading medical device maker Terumo announced today that it has signed a definitive agreement to acquire UK-based OrganOx, a specialist in organ-preservation devices, for $1.5 billion. The deal, signed on Aug. 23, will make OrganOx a wholly owned subsidiary of Terumo once US regulators grant the necessary approvals and permits. The Japanese company said the acquisition is a strategic step to enter the organ-transplant sector, which has significant growth potential and unmet needs. The statement is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections